MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexeo Therapeutics (LXEO) Earnings Date & Reports
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases... Show more
A.I. Advisor
published Earnings
LXEO is expected to report earnings to rise 10.00% to -33 cents per share on November 04
Q3'26
Est.
$-0.33
Q2'26
Beat
by $0.46
Q1'26
Beat
by $0.49
Q4'25
Beat
by $0.59
Q3'25
Beat
by $0.51
The last earnings report on August 12 showed earnings per share of -30 cents, beating the estimate of -75 cents. With 117.33K shares outstanding, the current market capitalization sits at 246.26M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
59
Web
https://www.lexeotx.com